The function of alpha globin in the context of oxygen transport in erythroid cells is well described. Recently the expression of alpha globin was shown to be upregulated upon specific apoptotic stimuli like cytokine deprivation or cisplatin treatment in the hematopoietic pro-B cell line, FL5.12. In contrast to alpha globin, beta globin or globin-like genes were expressed at a very low level or were not expressed at all. Further, we found that alpha globin was not associated with heme. Apoptotic cells neither produced hemoglobin nor displayed a phenotype of cells differentiating down the erythroid lineage. Also other cell lines of variable differentiation status (NIH3T3, HeLa, K562) upregulated alpha globin during treatment with apoptosis-inducing agents. Under IL-3-deprived conditions GFP-alpha globin accelerated the progression of apoptosis comparable to GFP-Bax. GFP-alpha globin was expressed at a low level and enrichment of FL5.12 cells expressing GFP-alpha globin was difficult even in the presence of IL-3. Caspase-8, -9 and -3 as well as the proapoptotic factor Bax and cytochrome c were activated. Antisense alpha globin downregulated the expression of endogenous alpha globin und reduced caspase activity. Taken together these data indicate that alpha globin is a new and crucial factor in apoptosis especially supporting the mitochondrial pathway.
Introduction
Apoptosis or programmed cell death (PCD) is a physiological process that has been described in all multicellular organisms studied thus far. PCD is a fine-tuned process that coordinates the removal of hazardous or damaged cells in order to maintain tissue homeostasis. 1 Depending on the origin of the death signal two major pathways can be distinguished: (a) the intrinsic pathway that requires de novo transcription and translation, and (b) the death receptor signaling pathway which is independent of macromolecule synthesis. The intrinsic apoptotic process occurs as a consequence of cellular stress and is mediated by the release of cytochrome c (cyt c) from the mitochondria. It further requires the induction of specific genetic programs by transcription factors. For example, p53, a negative regulator of cell growth, is upregulated in cells exposed to UV light and subsequently induces factors that support apoptosis. 2 Bax has been identified as a p53 immediate early response gene while p53 downregulates Bcl-2 in M1 myeloid leukemia cells. 3 Death receptor signaling promotes cell death by recruitment and activation of caspases. Caspases exist in cells in an inactive form and become activated upon induction of apoptosis. 4 In this pathway, the mitochondrion-dependent signaling is employed as an amplification loop. 5 Survival and growth of hematopoietic cells, like FL5.12, depend on interleukin-3 (IL-3). IL-3 acts by binding to its specific cell surface receptor composed of alpha and beta chain. Maintenance of cell survival requires activation of Ras which is capable of activating both the Raf/mitogen-activated protein kinase and the PI3-kinase/Akt pathways. 6 The survival factor Akt phosphorylates and inhibits pro-apoptotic factors like caspase-9, 7 Bad, and FKHRL1 transcription factor. 8 While phosphorylated caspase-9 is defective in processing procaspase-9 in the apoptosome, phosphorylated Bad and FKHRL1 are sequestered by 14-3-3 protein in the cytosol. IL-3 deprivation results in dephosphorylation and release of Bad and FKHRL1 from 14-3-3 and thereby their activation.
Alpha globin was the first gene to be cloned and the first complex protein whose three-dimensional structure was solved. (9, 10) Globins belong to the large group of hemecontaining proteins. 11 Two alpha and two beta globin chains form adult hemoglobin (HbA) which has a central role in oxygen transport. In the 1960s it was found that excess of alpha globin chains, as seen in patients with beta-thalassemia, were unstable and precipitated, a process leading to hemolysis of normoblasts and red blood cells. 12 Recently the natural chaperone of alpha globin, alpha hemoglobin stabilizing protein (AHSP), was characterized. 13 AHSP stabilizes free alpha but not beta globin both in vitro and in vivo and binding was shown to happen independently of heme. Studies in lens fibres found alpha globin to be expressed in normal lenses and to be downregulated in the pre-cataractous lens. Lenses undergo an apoptosis-like process during development, a process that results in removal of organelles and nuclei from lens fibre cells. In cataractous lenses organelles are not properly removed. 14 We have previously performed gene expression profiling of FL5.12 cells upon induction of apoptosis using cDNA microarrays. Clustering analysis has shown that 315 genes or ESTs were differentially regulated after IL-3 deprivation. 15 The most prominent upregulated gene was alpha globin. Devireddy and co-workers independently reported the dramatic increase of alpha but not beta globin in FL5.12 cells after IL-3 deprivation. 16 FL5.12 cells ectopically expressing alpha globin displayed accelerated apoptosis progression and increased caspase activity. 17 The primary objective of the present study was to analyze more closely the function of alpha globin in PCD. We compared wildtype FL5.12 cells with cells expressing GFP-alpha globin or antisense alpha globin. We also studied the expression of alpha globin in other cell lines after induction of apoptosis and noticed that upregulation of alpha globin was not restricted to FL5.12 cells, but seemed to be a relatively common phenomenon in cells undergoing apoptosis.
Material and methods

Cell lines, treatments, and TUNEL assay
Murine fibroblast cells, NIH3T3 (ATCC, CRL-1658) were grown in MEM Alpha medium supplemented with 15% heat-inactivated fetal bovine serum (HyClone), 1% sodium pyruvate (Invitrogen), 1% non-essential amino acids (Invitrogen), 2 mM L-glutamine (Invitrogen), and 10 mg/l gentamicin (Invitrogen). NIH3T3 cells were 50% confluent when treatment with cisplatin (20 µM) or staurosporine (STS) (1 µM) was started. Controls were left untreated or grown in the presence of DMSO.
HEK293T-derived Phoenix Eco packaging cell line and HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS) (BioConcept) and 1% Penicillin-StreptomycinFungizone (250 ng/ml) (BioConcept). Treatment with cisplatin (20 µM) or STS (0.5 µM) was started when HeLa cells were 50% confluent. Cells growing in normal medium or treated with DMSO (1:500 dilution) served as controls.
Human K562 cells were cultured in RPMI 1640 medium with 10% FCS (BioConcept). Treatment of K562 cells with hemin (Sigma), 18 TRAIL (Sigma, 250 ng/ml in phosphate buffered saline (PBS)), STI571 (imatinib mesylate, 500 nM in DMSO) (Jürgen Mestan, Novartis), or DMSO as control was started at a cell density of 5 × 10 5 cells/ml. Mouse erythroleukemic J2E cells were kindly provided by Thomas Bittorf (University Rostock). All cell lines were cultivated at 37
• C in a 5% CO 2 humidified atmosphere.
Murine FL5.12neo cells stably transfected with a vector for G418 resistance were kindly provided by Dr. Korsmeyer (Dana Faber Cancer Institute, Boston, US). These cells were used in all experiments and are referred to as FL5.12 cells. Cells were grown in RPMI 1640 medium with 10% heat-inactivated FCS (BioConcept), 1% Penicillin-Streptomycin-Fungizone (BioConcept), 100 µM β-mercaptoethanol (Invitrogen), G418 sulfate (200mg/l), and mouse recombinant interleukin 3 (IL-3) (1 ng/ml, Sigma). For treatment, FL5.12 cells were seeded at a density of 2 × 10 5 cells/ml and subjected to cisplatin (20 µM in H 2 O), STS (20 nM in DMSO), doxorubicin (DOXO, 40 nM in H 2 O), or tumor necrosis factor alpha (TNF-α, 2 ng/ml in PBS containing 1% bovine serum albumin (BSA)) and cycloheximide (CHX, 1 µg/ml in DMSO). STS, DOXO, TNF-α and CHX were purchased from Sigma Aldrich (St. Louis, MO, USA). For IL-3 deprivation experiments cells were washed three times with medium lacking IL-3 before they were cultured in IL-3-free medium. Control cells growing in medium containing IL-3 were subjected to the same washing. Pan caspase inhibitor zVAD-fmk (Sigma, 50 µM in DMSO) was used to assess caspase inhibition in IL-3 deprived FL5.12 cells. To study DNA fragmentation, 1 × 10 6 cells were subjected to terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining using the In Situ Cell Death detection kit (Roche). Protocol was performed as described by the manufacturer: Cells were washed with PBS, fixed with 2% paraformaldehyde (PFA) in PBS, pH 7.4 for 1 h at room temperature, and then permeabilized with 0.1% Triton-X 100 in 0.1% sodium citrate for 2 min on ice. The TUNEL reaction with terminal deoxynucleotidyl transferase (TdT) and tetramethylrhodaminelabeled nucleotides was performed for 1 h at 37
• C in humidified atmosphere and stopped by washing with PBS. TUNEL-positive cells were monitored using a FACS Calibur (Becton Dickinson) (FL2, 550/30 nm).
Caspase profiling
The ApoAlert TM Caspase Assay Plate (Becton Dickinson) was used to assay the activity of caspases cleaving AMC-labeled VDVAD, DEVD, IETD and LEHD in a 96-well format. Briefly, transduced FL5.12 cells were growing with and without IL-3 for 12 h. 2 × 10 5 cells per well were analyzed. Single measurements were performed for cells growing with IL-3. For cells growing in medium lacking IL-3 duplicates were analyzed. Cells were lyzed on ice for 10 min with lysis buffer provided with the ApoAlert TM kit, transferred to the caspase assay plate coated with immobilized, fluorogen-labeled caspase substrates and incubated at 37
• C for 1.5 h. Fluorescence intensity was monitored after 0 and 1.5 h using the Analyst R GT Reader (405 nm excitation, 460 nm emission, Bucher Biotec). Caspase profiling was repeated once and the cleavage status of each caspase was further confirmed by Western blotting.
DEVDase assay
FL5.12 cells ectopically expressing GFP or antisense (AS) alpha globin were grown in the presence or absence of IL-3 for 14 h. DEVDase activity was measured using the Caspase-3 Colorimetric Assay kit (BioVision). Briefly, 1.5 × 10 6 cells were lyzed in 70 µl cell lysis buffer. Ten µl lysates were mixed with 40 µl cell lysis buffer, 50 µl 2x reaction buffer, and 5 µl 4 mM DEVD-p NA (200 µM final concentration) and incubated at 37
• C for 1.5 h in a 96-well optical plate (Nalge Nunc). Triplicates were read at 405 nm using a GT Analyst Reader.
Total RNA isolation
Total RNAs were purified from FL5.12, NIH3T3, HeLa, and K562 cells using an RNeasy spin column system according to the manufacturer's instructions (Qiagen). Briefly, cells were pelleted, lyzed with RLT TM lysis buffer and subsequently homogenized using QIAshredder TM spin columns (Qiagen). Isolation of total RNA was performed with a silica-gel-based membrane technology (RNeasy Mini Kit, Qiagen). RNase-free DNase (Qiagen) kit was used to avoid DNA contamination in the isolated RNA. RNA quality assessing 18S and 28S ribosomal bands was analyzed in an Agilent 2100 LabChip Bioanalyzer using RNA 6000 Nano Chips TM (Agilent Technologies). RNA concentration and purity (A260/A280nm) were measured using the BioSpec-mini TM spectrophotomer (Shimadzu).
Affymetrix DNA chip
Total RNA was converted into double-stranded cDNA using Superscript II reverse transcriptase and an oligo(dT) primer with a T7 RNA polymerase promoter site at the 5' end (Invitrogen). 5 µg cDNA were used in an in vitro transcription in the presence of biotinylated ribonucleotides and T7 RNA polymerase to produce labeled cRNA (Enzo Diagnostics of Farmingdale). 15 µg cRNA were randomly fragmented by incubating in 40 mM Tris-acetate, pH 8.1, 100 mM potassium acetate, and 30 mM magnesium acetate at 94
• C for 35 min. Affymetrix Murine Genome U74v2 gene chips (Affymetrix, San Jose, CA) were hybridized, washed, and stained according to the protocol. 19 Fluorescence intensities for the individual oligonucleotide probes on the arrays were determined with a GeneChip system confocal scanner (Hewlett Packard) and analyzed as previously described. 20 All chips were prepared in duplicates.
Quantitative PCR (QPCR)
Total RNA was reverse transcribed using Omniscript TM RT kit (Qiagen) and rRNasin R RNase inhibitor (Promega). cDNAs were subjected to 40 rounds of amplification in the presence of TaqMan R Master Mix (Applied Biosystems) using the ABI Prism 7700 sequence detection system as described by the manufacturer (Applied Biosystems). Sequence-specific primers and probes labeled with a reporter, 6-carboxyfluorescein (6-FAM), and a quencher, 6-carboxytetramethylrhodamine (6-TAMRA), were designed with the primer express software (Applied Biosystems) or ordered as ready-to-use primer and probe mixes (Assay on Demand, Applied Biosystems). The following specific primer/probe sets were used: mouse alpha globin forward primer: 5'GCCTTGTCTG-CTCTGAGCG, reverse primer: 5' CTTGAAGTTGAC-GGGATCCAC, probe: 5'CCTGCATGCCCACAAGCT-GCG; human alpha globin forward primer: 5'TCCC-CACCACCAAGACCTAC, reverse primer: 5'CCTT-AACCTGGGCAGAGCC, probe: 5'CCCGCACTTC-GACCTGAGCCA; mouse AHSP forward primer: 5'TTGTGGTTCATGACTGGGTGA, reverse primer: 5'CCTGTCTTGCTCCTCCTGCT, probe: 5'ACCAA-CTATTACAAGAAGCTCGTGCATG; mouse heme oxygenase 1 forward primer: 5'CTCACTGGCAGG-AAATCATCC, reverse primer: 5'ACCTCGTGGAG-ACGCTTTACA, probe: 5' CCTGGAGGAGGAGA-TTGAGCGCAAC; mouse beta globin: Assay-onDemand Gene Expression product, Mm00731743 mH; human beta globin: Assay-on-Demand Expression product, Hs00747223 g1; eukaryotic ribosomal RNA (18S rRNA): Genomic Assay, 4310892E.
10 ng cDNA were used as template for real time RT PCR. Specific amplification was detected as an increased fluorescence signal of 6-FAM during the amplification cycle. The relative quantity of specifically amplified cDNAs was calculated using the comparative-threshold cycle method with interspecific 18S ribosomal RNA as endogenous reference according to the manufacturer's instructions (Applied Biosystems, User Bulletin #2, ABI PRISM 7700). No template controls (NTC) and no reverse transcriptase controls (noRT) were performed in parallel to exclude transcript unspecific amplification.
Western blotting
For preparation of whole cell lysates, cells were washed once with ice-cold PBS and then lyzed in ice-cold NET buffer (0.05 M Tris-HCl pH 7.5, 50 mM NaCl, 5 mM EDTA, 1% Nonidet P-40), PBS and NET were supplemented with Complete protease inhibitor cocktail (Roche Diagnostics). To remove cellular debris the lysates were centrifuged at 14 000 × g .
Separation of cytosolic and membrane proteins was done to evaluate localization of Bax, Bid, and cytochrome c. 2 × 10 6 FL5.12 cells were washed in PBS and resuspended in 200 µl STE buffer (0.25 M sucrose, 20 mM Tris-HCl, pH 8, 0.1 mM EDTA) supplemented with protease inhibitor cocktail. Cells were homogenized with a pellet pestle (Kontes Glass Company, NJ, USA) and a 30G1/2 Microlance needle (Becton Dickinson). Cell debris, intact cells and nuclei were removed by centrifugation at 1000 × g for 5 min at 4
• C. The supernatants were centrifuged at 80 000 × g for 1 h in a Beckman Airfuge to pellet the mitochondrial and microsomal fractions. Supernatants were precipitated with 14% trichloroacetic acid on ice for 30 min, centrifuged and washed twice with cold acetone. All pellets were dissolved in 30 µl Laemmli sample buffer, boiled for 3 min and 20 µl from each fraction were loaded in 12% sodiumdodecylsulfate polyacrylamide (SDS PAGE) gels.
For all Western blots either 12% SDS PAGE or NuPage R 4-12% Bis-Tris gels (Invitrogen) were used. Gels were blotted onto Protran R nitrocellulose transfer membrane (Schleicher & Schuell) using a Trans-Blot semidry blotting apparatus (BioRad). Membranes were blocked with 5% milk powder (Rapilait, Migros, Switzerland), 1% Tween 20 (Fluka) in TBS (TRIS-buffered saline), and probed with anti-Actin polyclonal 1:1000 (Santa Cruz I-19), anti-Bax polyclonal 1:3000 (Santa Cruz N-20), anti-Green fluorescent protein (GFP) monoclonal 1:1000 (Roche), anti-Calnexin polyclonal 1:500 (Santa Cruz C-20), anti-cytochrome c monoclonal 1:500 (BD Pharmingen), anti-hemoglobin polyclonal 1:1000 (ICN Cappel), anti-Bid polyclonal 1:1000 (Cell Signaling), anti-caspase-2 monoclonal 1:500 (Alexis Biochemicals 11B4), anti-cleaved caspase-3 (Asp175) polyclonal 1:1000 (Cell Signaling), anti-caspase-7 polyclonal 1:100 (Santa Cruz K-20), anti-caspase-8 monoclonal 1:500 (Alexis Biochemicals 1G12), and anti-caspase-9 monoclonal 1:500 (Stressgen Biotechnologies) antibodies. Secondary antibodies (BioRad) were HRP-conjugated goat anti-mouse IgG 1:5000, goat anti-rabbit IgG 1:5000, and rabbit anti-goat IgG 1:1000. All antibodies were diluted in TBS + 1% Tween 20 or blocking buffer. The proteins were visualized using Lumi-Light PLUS Western Blotting Substrate (Roche) or ECL Western Blotting Detection Reagents (Amersham). Blots were stripped for reuse using Re-Blot Western Blot Recycling (Chemicon) for 10 min at room temperature. Intensities of the protein bands were evaluated using a BioRad Imager and Quantity-One software (BioRad).
Immunofluorescence microscopy
FL5.12 cells growing with or without IL-3 for 12 h were washed once with PBS, resuspended in 300 µl PBS, spun on object trays with a Cytospin (Shandon Southern), and fixed with 4% PFA for 15 min. Thereafter the cells were permeabilized and blocked for 20 min with PBS containing 0.1% Triton R X-100 (BioRad) and 10% FCS. Cells were stained with anti-hemoglobin polyclonal antibody (ICN Cappel) diluted 1:200 in the blocking solution for 30 min. Cells were washed three times with PBS, then incubated with goat anti-rabbit IgG-Alexa Fluor 546 (Molecular Probes) diluted 1:200 in PBS containing 0.1% Triton X-100 and 1% FCS for 30 min, and washed three times with PBS.
Cells were cover-slipped using DAKO mounting medium containing 1 µg/ml 4 ,6-diamidino-2-phenylindole (DAPI). Cells were analyzed using a Nikon Eclipse TE 2000-S equipped with a Nikon digital camera DXM1200. eGFP was excited at 460 to 500 nm, Alexa Fluor 546 at 510 to 560 nm, and DAPI at 340 to 380 nm. To avoid cross-talk between fluorescence signals and to reject non-specific fluorescence a 510 to 560 nm bandpass filter was used for eGFP, a 590 nm filter for Alexa Fluor 546, and a 435 to 485 nm bandpass filter for DAPI (Chroma Technology Corporation).
Determination of heme, hemoglobin, and differentiation stage
Detection of heme was performed according to the protocol described by Sassa et al. 21 1 × 10 6 cells were pelleted, mixed with 0.5 ml 1 M oxalic acid, and immediately heated for 30 min at 95
• C. Cells in 1 M oxalic acid without heating served as a negative control. After cooling, triplicates of 150 µl were analyzed fluorometrically using the Analyst GT Reader (excitation = 400 nm, emission = 662 nm) (Bucher Biotec). Dilutions of 125-2.5 nM hemin in a solution of methanol and 0.01 M KOH (1:1), containing 1% BSA served to evaluate a standard curve.
Hemoglobin assay was performed as described by Worthington et al. 22 Briefly, 1 × 10 6 cells were washed twice with PBS, and permeabilized in 500 µl water containing 0.01% Nonidet R P-40 (Fluka). Hemoglobin standard was freshly prepared by dissolving human hemoglobin (Sigma) in water. 2,7-Diaminofluorene (DAF) (Sigma) stock solution was prepared by dissolving 10 mg/ml DAF in 90% glacial acetic acid. To initiate the color reaction 1.5 ml DAF working solution containing 100 µl DAF stock solution, 60 µl 30% hydrogen peroxide, and 6 M urea in 10 ml 0.1 M Tris buffer, pH 7, were added to the cell suspension or the hemoglobin standards, respectively, vortexed and incubated at room temperature for 10 min. All reactions were performed in polypropylene tubes. Generation of fluorene blue was detected by measuring the absorbance at 610 nm.
The differentiation stage of FL5.12 cells growing with and without IL-3 was evaluated by May-Grünwald-Giemsa staining using Diff-Quik R (Dade, Behring).
Gateway expression cloning and retroviral transduction
Genes of interest were synthesized with PCR. cDNA, derived from total RNA of FL5.12 or HeLa cells, served as a template. Oligonucleotide primers contained attB sites at their respective 5 ends (forward primer: GGGG ACA AGT TTG TAC AAA AAA GCA GGC TCC, reverse primer: GGGGAC CAC TTT GTA CAA GAA AGC TGG GTA) to render cDNA templates compatible with the GATEWAY TM cloning technology (Life Technologies). Primers for human bcl-x L (5 ATGTCTCAGAGCAACCGGGAGCTGG, 5 CTATTTCCGACTGAAGAGTGAGCCCAGCAG), human bax (5 ATGGACGGGTCCGGGGAGCAGCC-CAGAGGC, 5 CTAGCCCATCTTCTTCCAGATGGT-GAGCGAGGC), mouse alpha globin (5 ATGGTGCTC-TCTGGGGAAGAC, 5 CTAACGGTACTTGGAGGT-CAGCAC), and antisense mouse alpha globin (5 TAAA-CGGTACTTGGAGGTCAGCACGGTG, 5 ATGGTG-CTCTCTGGGGAAGACAAAAGCAAC) were used.
In the BP TM clonase reaction PCR products were first cloned into the pDONR TM (Life Technologies) vector and were then verified by sequencing. In the second LR TM clonase reaction cDNA inserts were transferred into retrovirus-derived expression vectors. Two destination vectors, CRU5-FLAGgw-IRES-GFP and CRU5-Nterm-GFPgw, were used, both generated by Dr. Benoit Pierrat (Novartis Basel). Both vectors contain a constitutive cytomegalo virus (CMV) promotor for expression of desired genes, sequences from long terminal repeats (5 RU, 3 LTR) rendering the plasmid a retroviral vector, Gateway recombination cassettes (attR), and enhanced GFP (eGFP). For simplicity reasons eGFP is referred to as GFP. Expression vector for antisense alpha globin contained an N-terminal FLAG tag, the reverse complement sequence of alpha globin with a stop codon in the first codon, and an internal ribosomal entry site for eGFP. All other proteins of interest were used as N-terminal eGFP-fusion constructs. Once constructs had been verified by restriction digest they were transfected using the calcium-phosphate method into Phoenix packaging cells expressing an ecotropic envelope protein.
Virus containing supernatants were then used to transduce FL5.12 or NIH3T3 cells. 23 Efficiency of transduction was followed by monitoring GFP expression levels in a FACS Calibur instrument (Becton Dickinson). One to two rounds of cell sorting were used to enrich GFP-expressing cells.
Results
Alpha globin mRNA is strongly upregulated in cytokine-deprived FL5.12 cells, while other globins or globin-like genes are expressed at low or undetectable levels Incyte cDNA microarray experiments and Northern blot analyses have shown that alpha globin transcript is upregulated upon cytokine deprivation in FL5.12 cells. 15 We confirmed the results using Affymetrix chip technology and quantitative real time RT PCR of FL5.12 cells growing with and without IL-3 for 0, 8, 12, 16, and 20 h (Figure 1a and c). We used 18S ribosomal RNA as endogenous control to normalize for differences in the amount of total RNA. GAPDH, another frequently used housekeeping gene, was found to be downregulated upon apoptosis induction and was therefore not suitable as a reference in RT QPCR (data not shown). We found that alpha globin was expressed in FL5.12 cells. We measured a threshold cycle of 16 cycles for the housekeeping gene, 18S ribosomal RNA, compared to 22 cycles for alpha globin transcript. The largest incremental increase of alpha globin transcript of about 9.7-fold in cells growing without IL-3 was observed within the first 8 h after IL-3 removal. Maximal expression of alpha globin (11-fold induction) was reached after 12 h. 16 and 20 h after IL-3 deprivation alpha globin expression decreased ( Figure 1c) . Thus, alpha globin is regulated like a delayed-response gene. 24 To check if other globin genes are expressed and regulated under death-inducing conditions, we analyzed expression patterns from chip experiments of IL-3-deprived and control FL5.12 cells. Transcript for myoglobin, a globin protein known to function as an oxygen carrier in muscles, heart and other tissues was not detectable in FL5.12 cells. Probes for neuroglobin, the oxygen carrier in the brain 25 or cytoglobin, the most recently found globin, 26 were not spotted on the chip and were not further investigated. Additionally, neither zeta nor epsilon or gamma globin, resembling the alpha-and beta-like globins and expressed in early embryonic life, were detectable. Beta globin was not detected in FL5.12 cells as assessed by gene chip analysis. However, after cytokine removal the signal for beta globin was found to slightly increase, but according to Affymetrix chip analysis beta globin was still termed absent ( Figure 1b) . To analyze more closely the potential upregulation of beta globin we performed RT QPCR using beta globin specific primers and probe. In mouse, two copies of the beta globin gene exist, beta globin major (Hbb-b1) and minor chain (Hbb-b2), which share 96% homology at nucleotide level. Neither gene chip arrays nor RT QPCR could discriminate between beta major and minor chain. The very low expression levels for beta globin were confirmed by RT QPCR. The upregulation of beta globin message upon IL-3 deprivation, however, appeared much stronger in RT QPCR than on Affymetrix chips ( Figure  1d ). For comparison, K562, a human chronic myeloid leukemia cell line, was analyzed. K562 cells have been reported to express only beta globin-like genes, epsilon and gamma globin, but not beta globin itself when forming embryonic and fetal hemoglobin (Hb Gower, Hb Portland, and HbF). 27 In RT QPCR experiments, the detection threshold for beta globin in K562 cells was reached after 30 cycles similar to our results for beta globin in non-apoptotic FL5.12 cells thereby confirming the very low beta globin transcript levels in both cell lines.
Alpha globin protein is upregulated upon IL-3 deprivation
In order to show that alpha globin protein was similarly regulated as its mRNA, we performed Western blot analysis and immunostaining using a hemoglobin antibody that detects both the alpha and the beta globin chain (data not shown). We found a comparable expression profile for the protein as seen for the transcript (Figure 2b ). Having shown a good correlation between transcript and protein level we predominantly used RT QPCR to evaluate expression. Interestingly, in most experiments we observed two protein bands with approximately 0.5 kD difference. The intensity of both bands increased upon IL-3 deprivation. We assumed that both protein bands represent alpha globin since beta globin mRNA was expressed only at its detection limit in FL5.12 cells. Further, the hemoglobin antibody detected a single band for alpha and beta globin deriving from mouse erythroid J2E cells (Figure 2a) . The globin monomers in J2E cells corresponded to the smaller 14 kD globin band in FL5.12 cells. The slower migration of the 14.5 kD band could be due to unknown posttranslational, secondary modifications. Immunostaining of FL5.12 cells with hemoglobin antibody detected accumulation of alpha globin protein in the cytoplasmic rim ( Figure 3 ).
Differential expression of alpha globin after treatment with cisplatin, doxorubicin, staurosporine, or cycloheximide and tumor necrosis factor alpha Next, we quantified alpha globin message by RT QPCR after treatment with cytotoxic reagents. We used compounds known to induce cell death along different pathways. Treatment was continued until 50% of the FL5.12 cells were dead according to trypan blue staining. Both cisplatin and doxorubicin (DOXO) induced alpha globin weakly by about 2.4-fold. In comparison, deprivation of IL-3 for 20 h increased alpha globin message by 8-fold (Figure 4a ). The broad-spectrum protein kinase inhibitor, staurosporine (STS), 28 known to inhibit multiple kinasedependent survival pathways, triggered apoptosis faster than seen in cytokine-deprived cells, but did not change alpha globin levels after 4, 8, or 12 h (Figure 4b ). Last, we examined the tumor necrosis factor alpha (TNF-α) death receptor signaling pathway. This pathway triggers apoptosis without de novo transcription and translation. 29 TNF-α (2 ng/ml) alone did not induce apoptosis. It has been shown earlier that FL5.12 cells need to be sensitized by cycloheximide (CHX), a translation inhibitor, to undergo apoptosis by TNF-α treatment. 30, 31 While treatment with CHX (1 µg/ml) alone did not change viability either, the combined treatment of TNF-α and CHX was toxic leading to 50% trypan blue-positive cells after 12 h. Neither TNF-α nor CHX changed alpha globin transcript or protein levels. In contrast, combined treatment with CHX/TNF-α caused a decrease of transcript levels ( Figure 4c ).
In summary, alpha globin was specifically induced in apoptosis triggered by cytokine withdrawal as well as to some extent by DNA-damaging drugs, 30, 32 but not by death receptor stimulation or protein kinase inhibition. 33 Alpha globin is not associated with heme, and apoptotic FL5.12 cells neither produce hemoglobin nor differentiate
We next addressed the question whether alpha globin was associated with heme. We assumed that expression of genes involved in heme biosynthesis should parallel alpha globin expression if alpha globin was associated with heme. Heme is the prosthetic group in globins and cytochromes that coordinately binds iron for oxygen transport. 11 Interestingly, we found that neither aminolevulinic acid synthase 1 (ALA-S1) nor porphobilinogen deaminase (PBGD), two representatives of eight enzymes involved in heme biosynthesis, were upregulated as assessed by gene chip expression analysis (data not shown). We conducted two experiments to verify this observation. First, we analyzed expression of heme oxygenase 1 (HO-1) . HO-1, also called heat shock protein Hsp32, bears important functions in hemoglobin and especially heme degradation and prevention of cellular damage. HO-1 is dramatically induced upon cellular stress, caused by free heme, heavy metals, UV, low oxygen treatment or heat, 34 and remains high for hours. We assumed that HO-1 would increase under IL-3-deprived conditions if alpha globin were associated with heme and were degraded during apoptosis. While alpha globin levels increased in FL5.12 cells growing without IL-3, HO-1 remained unchanged, in contrast to cells treated with heme which responded well with induction of HO-1 (Figure 5a) .
Second, we measured cellular heme concentrations as described previously. 21 Detection of heme is based on the conversion of heme to its fluorescent porphyrin derivative by removal of heme iron under acidic reducing conditions. In parallel to FL5.12 cells growing with and without IL-3, we analyzed K562 cells that have been reported to increase globin expression and generate hemoglobin upon treatment with doxorubicin in subtoxic concentrations. 35 In K562 cells, we found basal heme concentrations about 17-fold higher than in FL5.12 cells. Whereas heme levels increased significantly in K562 cells upon doxorubicin treatment, levels remained unchanged in growth factor deprived FL5.12 as compared to control cells (Figure 5b) .
In parallel, we measured the intracellular hemoglobin concentration in FL5.12 and K562 cells using the method of Worthington et al. 22 The hemoglobin assay is based on the oxidation of 2,7-diaminofluorene (DAF) by the pseudoperoxidase activity of hemoglobin in the presence of peroxide. As expected, K562 cells increased hemoglobin levels about 10-fold under doxorubicin treatment. In contrast, hemoglobin was not detected in FL5.12 cells growing with or without IL-3 ( Figure 5c ).
To check whether FL5.12 cells differentiated concomitant to apoptosis induction and alpha globin upregulation, we investigated cell morphology using hematological staining. In FL5.12 cells growing in the absence of IL-3 we observed moderate cell shrinkage, a decrease in nucleoli, and the occurrence of cell debris (Figure 5e ). Besides the morphological changes typical of cells undergoing apoptosis, no signs of differentiation were detected. NIH3T3, HeLa, and K562 cells differentially express alpha globin upon induction of apoptosis
To study whether upregulation of alpha globin occurs in cell lines other than FL5.12 we investigated cell lines of different origin, differentiation status and species. Table 1 summarizes the basal expression, as assessed by RT QPCR, of alpha and beta globin in the four cell lines tested. To study the effect of apoptosis induction on alpha globin expression the cells were treated with different cytotoxic compounds. The treatment was stopped and RNA was isolated when 50% of the cells were dead according to trypan blue staining or microscopic observation. NIH3T3, an immortalized mouse fibroblast cell line, displayed similar regulation of alpha globin mRNA as FL5.12 cells except that overall expression levels of alpha globin were very low. In NIH3T3 cells alpha globin levels remained low after STS treatment, but cisplatin dramatically induced alpha globin expression (60-fold) (Figure 6a ). The human epithelial cervix cancer cell line, HeLa, displayed opposite expression profiles. While alpha globin expression was unaltered after treatment with cisplatin, it was increased after STS treatment (Figure 6b ). Cisplatin or STS do not induce apoptosis in K562 cells 36, 37 (and our unpublished observations). However, combined treatment with TNF-related apoptosis inducing ligand (TRAIL) and STI571, an inhibitor of bcr-abl tyrosine kinase activity, led to apoptosis with elevated alpha globin levels (Figure 6c ). In summary, alpha globin expression increased in all four different cell lines after specific drug treatments.
We then examined the four cell lines for beta globin expression by RT QPCR (Table 1 ). NIH3T3 and HeLa cells did not express beta globin under normal or apoptotic conditions. As already mentioned beta globin is not expressed in K562 cells, so we measured very low levels of beta globin transcript with a detection threshold of 30 cycles. As for FL5.12 cells growing in the absence of IL-3, treatment of K562 cells with STI571/TRAIL, resulted in upregulated beta globin levels by a factor of 4 ( Figure 6c ).
Expression of GFP-alpha globin in FL5.12 cells
To ectopically overexpress alpha globin in FL5.12 cells we combined retroviral transduction and subsequent fluorescent activated cell sorting (FACS) to enrich FL5.12 cells expressing alpha globin. We used an N-terminal GFPalpha globin fusion construct to ensure concomitant sorting of GFP and alpha globin. Transduction efficiencies of GFP-alpha globin were low. We measured 6% GFPpositive cells compared to 82 and 65% for GFP-Bax and GFP control clones, respectively ( Figure 7) . Two rounds of sorting were needed to enrich GFP-alpha globin expressing FL5.12 cells, whereas high expression levels of GFP-Bax were obtained without enrichment. Both GFPBax and GFP-alpha globin expressing cells were healthy and displayed similar proliferation rates in the presence of Figure 7 . Enrichment of GFP-alpha globin expressing FL5.12 cells. GFP expression profiles of FL5.12 cells transduced with GFP or GFP-Bax prior to sorting, and GFP-alpha globin prior to sorting (black, 6%), after one (light grey, 10%) and two (dark grey, 72%) rounds of sorting. GFP expression was monitored in the FL1-H channel of a FACS Calibur.
IL-3 (data not shown). GFP-alpha globin appeared mostly evenly distributed in the cytoplasm (not shown).
GFP-alpha globin accelerates apoptosis induced by IL-3 deprivation in a dose-dependent manner and reduces increase of endogenous alpha globin
We followed apoptosis progression by TUNEL staining in transduced FL5.12 cells after cytokine deprivation. We compared cells expressing GFP-alpha globin, which were enriched by one or two steps of sorting ( Figure 7) , with cells expressing GFP, GFP-Bcl-x L or GFP-Bax. Protein expression was studied by Western blot using an anti-GFP antibody (Figure 8a ). Cells grown in the presence or absence of IL-3 for 12 h were subjected to TUNEL staining. All transduced FL5.12 clones growing with IL-3 were TUNEL-negative (data not shown). Significant differences in the progression of apoptosis were observed after growth factor deprivation. GFP-Bax displayed obvious death-accelerating features with 39% TUNEL-positive cells, while GFP-Bcl-x L very efficiently rescued cells from death (< 1% TUNEL-positive cells) (Figure 8b ). FL5.12 (Figure 8b ) whereas 31% of cells expressing higher levels of GFP-alpha globin were TUNELpositive ( Figure 8b ). Experiments with GFP and GFP-alpha globin transduced NIH3T3 cells corroborated the observations made in FL5.12 cells. NIH3T3 cells tolerated accumulation of alpha globin under normal growth conditions, but apoptosis induction with cisplatin caused faster cell death in cells overexpressing GFP-alpha globin than in cells expressing GFP, as evaluated by ATP depletion in the CellTiter-Glo Luminescent Cell Viability Assay (Table 2) .
We questioned whether the pro-apoptotic effect of GFP-alpha globin could also be prevented by Bcl-x L , an anti-apoptotic member of the Bcl-2 family. After two rounds of GFP-alpha globin enrichment, we transduced FL5.12 cells with GFP-Bcl-x L . Only three percent of the cells stained TUNEL-positive after 12 h without IL-3 indicating that Bcl-x L neutralized the pro-apoptotic effect of GFP-alpha globin efficiently (Figure 8b ). In summary, GFP-alpha globin accelerated cell death in a dosedependent manner and this process was neutralized by Figure 8 . Ectopically expressed GFP-alpha globin accelerates apoptosis in FL5.12 cells after IL-3 deprivation and reduces upregulation of endogenous alpha globin. Expression of GFP fusion proteins in FL5.12 cells transduced with GFP, GFP-Bcl-x L (Bcl-x L ), GFP-Bax (Bax), once and twice sorted GFP-alpha globin (α-globin 1x and α-globin 2x), and GFP-alpha globin plus GFP-Bcl-x L (α-globin + Bcl-x L ) were analyzed by SDS PAGE and Western blotting and probed with anti-GFP antibody (a). For each sample proteins from 1.5 × 10 6 cells were isolated. Transduced FL5.12 cells were grown in medium lacking IL-3 for 12 h and subsequently subjected to TUNEL staining. TUNEL-positive cells were monitored using a FACS Calibur. The markers depict TUNEL-positive cells in percentage (%) (b). FL5.12 cells ectopically expressing GFP, GFP-Bcl-x L , GFP-Bax, and twice sorted GFP-alpha globin were grown in the presence or absence of IL-3 for 14 h. Whole cell lysates were analyzed with 12% SDS PAGE and blotted with anti-hemoglobin antibody and reprobed with anti-actin antibody (c).
coexpression of Bcl-x L . The potencies of GFP-alpha globin and GFP-Bax to induce apoptosis in cytokinedeprived FL5.12 cells were comparable.
Interestingly, we observed that GFP-alpha globin decreased the upregulation of endogenous alpha globin. In FL5.12 cells expressing GFP-alpha globin only a weak increase of endogenous alpha globin was detected at protein level (Figure 8c ). This suggests that the observed enhancement of apoptosis in transduced FL5.12 cells is mainly due to the GFP-alpha globin, and upregulation of endogenous alpha globin might be prevented by negative feedback inhibition.
Pan caspase inhibitor, zVAD-fmk, delays apoptosis in FL5.12 cells expressing GFP-alpha globin and GFP-Bax
We further assessed the role of caspases in apoptosis accelerated by GFP-alpha globin. We measured DNA degradation of IL-3-deprived FL5.12 cells expressing GFP, GFPBax, or GFP-alpha globin in the presence of 50 µM zVADfmk, a broad-spectrum caspase inhibitor, or DMSO as control after 0, 14, and 22 h by TUNEL staining. After cytokine-withdrawal a moderate but significant inhibition of apoptosis by zVAD-fmk was observed in FL5.12 cells (Figure 9a ). Also higher doses of zVAD-fmk (100 µM and 200 µM) did not fully abrogate apoptosis in FL5.12 cells (data not shown). This suggests that either caspaseindependent processes were involved or that the concentration of zVAD-fmk was still too low. Cell death inhibition was most evident in the early phase of apoptosis in cells expressing GFP. Cells expressing GFP-alpha globin and GFP-Bax died significantly faster, 3-and 3.6-fold, respectively, than GFP expressing cells. Protection from cell death by zVAD-fmk was less pronounced in the cells expressing GFP-alpha globin or GFP-Bax than in GFP expressing cells. In the presence of zVAD-fmk, progression of apoptosis after 14 h was diminished by a factor of 4 in GFP expressing cells. In GFP-alpha globin and GFP-Bax expressing cells attenuation of apoptosis occurred but was less pronounced. While the pan-caspase inhibitor zVAD-fmk delayed apoptosis in IL-3-deprived FL5.12 cells, it did not prevent upregulation of alpha globin expression either at RNA (data not shown) or at protein level (Figure 9b ).
Involvement of different caspases in IL-3 deprivation-induced apoptosis in FL5.12 cells
Recent studies have shown that executioner caspases are activated by proteolytic cleavage whereas activation of apical initiator caspases requires monomeric pro-caspase dimerization rather than cleavage. First, we used Western blotting to assess the expression levels and the cleavage status of various caspases under IL-3-deprived conditions.
We used whole cell lysates of FL5.12 cells which were grown either in the presence or absence of IL-3 for 14 h. We observed cleaved caspase-3 in apoptotic but not in healthy FL5.12 cells, indicating that caspase-3 was activated ( Figure 10a ). Caspase-7 was neither detected as full length nor as cleaved protein (not shown). The intensity of the 55 kD band representing full length caspase-2 decreased slightly in cells growing without IL-3. Also, an additional protein band of 16 kD, most probably deriving from cleaved caspase-2, was detected in FL5.12 cells growing in the absence but not in the presence of IL-3 (Figure 10a ). Further, caspase-9 was processed in Figure 9 . zVAD-fmk diminishes apoptosis after cytokine deprivation in FL5.12 cells but not upregulation of alpha globin. FL5.12 cells transduced with GFP, GFP-Bax (Bax), and GFP-alpha globin (alpha globin) were cultured in medium lacking IL-3 either in the presence or absence of 50 µM zVAD-fmk (zVAD). After 0, 14, and 22 h cells were subjected to TUNEL staining (a). Whole cell lysates of FL5.12 cells grown with or without IL-3 for 12 h either in the presence or absence of 50 µM zVAD-fmk. Proteins were analyzed by SDS PAGE and Western blotting. The blot was probed with anti-mouse hemoglobin antibody and reprobed with anti-actin antibody (b). Figure 10 . Cleavage of caspase-2, -3, -9, and -8 in FL5.12 cells after withdrawal of IL-3. Whole cell lysates of FL5.12 cells growing with or without IL-3 or treated with 1 µg/ml CHX plus 2 ng/ml TNF-α for 14 h, were analyzed with SDS PAGE and Western blotting. Separate blots were prepared and in parallel probed with anti-caspase-2, anti-cleaved caspase-3, anti-caspase-8, and anticaspase-9 antibody.
cytokine-deprived FL5.12 cells but not in control cells (Figure 10a) . Interestingly, cleaved caspase-8 was also detected on Western blot. We compared caspase-8 cleavage in FL5.12 cells after IL-3 deprivation and CHX/TNF-α FL5.12 cells ectopically expressing GFP, GFP-Bcl-x L , GFP-Bax, GFP-alpha globin or cells cotransduced with GFP-alpha globin and GFPBcl-x L were grown with or without IL-3 for 14 h. Cell lysates were tested for the activity of caspases cleaving AMC-labeled IETD, LEHD, VDVAD, and DEVD. Duplicate measurements were analyzed. Fluorescence intensity was monitored after 1.5 h incubation, average intensities are shown in the table (405 nm excitation, 460 nm emission).
treatment and found that processing of caspase-8 in FL5.12 cells growing without IL-3 was weak compared to cells treated with CHX/TNF-α.
We also assayed the enzymatic activity of caspases cleaving AMC-labeled IETD, LEHD, VDVAD and DEVD substrates. IETD and LEHD peptides are relatively specific substrates for caspase 8 and 9, respectively. We found both caspase substrates to be cleaved in cytokine-deprived FL5.12 cells suggesting activation of caspase-8 and -9, thereby corroborating the results from immunoblotting. Also VDVAD and DEVD substrates which are predominantly cleaved by caspase-2 and caspase-3, were cleaved. However, due to very similar substrate requirements of caspases it cannot be fully excluded that also other caspases cleave the same substrates. Under these conditions cells transduced with Bax or alpha globin exhibited stronger enzymatic activity than GFP control cells for all caspase substrates tested (Table 3) .
Cytochrome c, Bid, and Bax are involved in IL-3 deprivation induced apoptosis
The observation of cleaved caspase-9, -8 and -2 in cytokine-deprived FL5.12 cells prompted us to study other proteins involved in the mitochondrial apoptosis pathway in alpha globin transduced FL5.12 cells. We performed a time course experiment with FL5.12 cells The bands of the cytosolic proteins in Figure 12a were quantitated using actin as endogenous reference to normalize expression. Expression values (n -fold) were calculated relative to expression at t = 0 h.
expressing GFP, GFP-alpha globin or GFP-Bax growing in the absence of IL-3. After 0, 10, 14, and 22 h, we separated whole cell lysates into cytosolic and membrane protein fractions by ultracentrifugation and investigated protein expression and localization of Bid, Bax, and cytochrome c by Western blotting. The intensities of the bands were quantified using a BioRad Imager. In general, after 22 h without IL-3, apoptosis had progressed so far that almost all proteins were degraded, as seen in Figure 11 from the control proteins actin and calnexin. In Bax and alpha globin expressing cells, full length Bid decreased faster than in GFP expressing cells (Figure 11a ), which hints to cleavage of full length Bid and generation of truncated Bid. Truncated, pro-apoptotic Bid has been reported to translocate to mitochondria, recruit and oligomerize Bax and permeabilize mitochondria. 38 Therefore, we investigated Bax localization and found that Bax translocated from the cytosol to the membrane fraction in all three investigated cell lines. Translocation occurred with fastest kinetics in Bax overexpressing cells. Both endogenous and GFP-Bax redistributed from the cytosolic to the membrane fraction. Accelerated Bax translocation was also detected in alpha globin expressing cells (Figure 11a , b, Table 4 ). Lastly, we tested whether cytochrome c was released into the cytosol. In Bax as well as in alpha globin expressing cells we observed cytosolic cytochrome c after 10 h, but in the GFP expressing control cells only after 14 h (Figure 11a) . Figure 11 . Translocation of Bax and cytochrome c, and disappearance of full-length Bid. FL5.12 cells transduced with GFP, GFP-alpha globin (α-globin), or GFP-Bax were grown in medium lacking IL-3 for 0, 10, 14, and 22 h. Cytosolic and membrane fractions were separated and proteins were analyzed by SDS PAGE and Western blotting. The blot containing cytosolic proteins was successively probed with anti-cytochrome c, anti-Bid, anti-Bax, and anti-actin antibody (a). The blot containing the membrane fraction was probed with anti-Bax, anti-calnexin and anti-actin (b). Actin served as endogenous reference to normalize expression of cytosolic proteins.
In summary, under conditions without IL-3 in all cells a decrease of full length Bid and translocation of Bax and cytochrome c were observed. These phenomena occurred with faster kinetics in both GFP-alpha globin and GFPBax expressing FL5.12 cells.
Effect of antisense alpha globin in FL5.12 cells
Above we have shown that enrichment of ectopic GFPalpha globin efficiently accelerated apoptosis in IL-3-deprived FL5.12 cells. To further confirm the crucial role of alpha globin as a pro-apoptotic factor in PCD we investigated how silencing of alpha globin expression affected progression of apoptosis in FL5.12 cells. Since two shRNA constructs tested failed to downregulate both alpha globin message and protein, we generated a retroviral antisense expression construct with an IRES for GFP and the reverse complement sequence of alpha globin containing a stop codon in the first codon. We demonstrated that antisense alpha globin reduced alpha globin protein. No band was detected in antisense alpha globin expressing cells as compared to GFP control cells in the presence of IL-3. In the absence of IL-3, however, alpha globin protein was detected, indicating that the antisense construct could not completely abolish the expression of endogenous alpha globin ( Figure 12 , Table 5 ). In order to assess the biological relevance of reduced alpha globin levels in FL5.12 cells we monitored DNA fragmentation and caspase activity in cells expressing GFP or antisense alpha globin in the presence or absence of IL-3 for 14 h. Under cytokine deprived conditions we deteceted only marginal reduction of DNA fragmentation in antisense alpha globin expressing cells as compared to GFP control cells (55 vs 60% TUNEL-positivity, data not shown). In contrast, the DEVDase activities were reduced by a factor of approximately 2 in cells transduced with antisense alpha globin as compared to GFP transduced cells lacking IL-3 (Table 5 ).
Discussion
FL5.12 is a hematopoietic cell line with typical characteristics of pro-B cells. Expression of genes characteristic for non-differentiated pro-B cells are well described. 39 However, expression of alpha globin in FL5.12 pro-B cells was detected only in 2000 in our lab. 15 We showed that expression of alpha globin was dramatically upregulated after induction of apoptosis. Expression at transcript and protein levels paralleled as assessed by RT QPCR and immunoblotting, respectively. No increase of alpha globin mRNA level was observed during the first hour of IL-3 deprivation. However, a strong incremental increase occurred within the following 7 h post cytokine withdrawal. The maximal expression was reached after 12 h, and was then followed by a gradual decrease after 16 and 20 h. From this kinetics we conclude that alpha globin is induced like a delayed-response gene, 24 in contrast to immediate-response genes such as transcription factors cfos or the early growth response genes. 40 Besides alpha globin, no other globin or globin-like genes were found to be significantly expressed in FL5.12 cells. Myoglobin, zeta, epsilon and gamma globin were completely undetectable as assessed by gene expression analysis. Also beta globin was termed to be absent, but after 16 h in the absence of IL-3 the signal increased, however, remained below detection according to Affymetrix chip technology. From RT QPCR we estimated very low expression but a strong increase of beta globin mRNA after IL-3 deprivation. Similarly, K562 cells exhibited beta globin levels at the detection limit and upregulated beta globin under apoptotic conditions, while NIH3T3 and HeLa cells did not express beta globin at all. Even though beta globin is expressed at very low levels it might contribute to apoptosis. The function of beta globin in the apoptotic process will be the subject of future studies.
Interestingly, we found that alpha globin upregulation was not restricted to FL5.12 cells, but was also observed upon apoptosis induction in non-hematopoietic and differentiated cells such as NIH3T3, HeLa, and K562 cells. This supports a novel role for alpha globin in PCD.
Besides alpha globin induction upon IL-3 deprivation we found alpha globin to be upregulated in FL5.12 cells treated with cisplatin, doxorubicin or methotrexate. These treatments induce a block in DNA synthesis. In contrast, we have shown that death receptor signaling by CHX/TNF-α, the broad-spectrum protein kinase inhibitor STS, camptothecin, a topoisomerase inhibitor inducing DNA strand breaks, or paclitaxel, a drug stabilizing microtubules, did not induce alpha globin expression. 17 While NIH3T3 cells showed similar alpha globin expression profiles after cisplatin and STS treatment as FL5.12 cells, HeLa cells displayed an exactly opposite regulation. This suggests that upregulation of alpha globin is not an unspecific signal for stress but specific for certain apoptotic pathways, and depends on the cell type.
It has been reported that treatment of undifferentiated cells with apoptosis-inducing compounds is paralleled by changes in the differentiation status. 41 We did not discover formation of hemoglobin or any other sign of differentiation down the erythroid lineage in apoptosing FL5.12 cells. Furthermore, we found that alpha globin was not associated with heme, the oxygen-binding prosthetic group of globin proteins. Therefore, we suggest that the role of alpha globin in death-committed FL5.12 cells is different from the well-established role in oxygen transport in erythrocytes. 42 During the past few years, alpha globin has been reported to be involved in other processes besides oxygen transport in erythrocytes. For instance, alpha globin has been found to be expressed in lens fibres in normal lenses and to be downregulated in the pre-cataractous lens. 16 Lenses undergo an apoptosislike process during development, a process that results in removal of organelles and nuclei from lens fibre cells. In cataractous lenses the organelles are not properly removed. This suggests that alpha globin plays a role in lens fibre differentiation.
14 Also, Yoshida and colleagues found that extraerythrocytic hemoglobin played a novel role in wound healing. Hemoglobin and globin, but not heme or protophorphyrin IX, were able to stimulate plasminogen activator biosynthesis and to increase fibrinolytic activity in human fibroblasts. 43 The molecular weights of alpha and beta globin monomers of erythroid cells are identical, and both chains appear as a single 14 kD protein band in Western blot analysis with the hemoglobin antibody we used. 44 In contrast, alpha globin in FL5.12 cells appears as a double band differing by 0.5 kD in size possibly due to posttranslational, secondary modifications. However, since we were not able to confirm the nature of the 14.5 kD band, we cannot fully exclude that it derives from an unidentified cross-reactive protein, that is also upregulated under apoptotic conditions. Different from our earlier publication 17 we now used an N-terminal GFP-alpha globin fusion construct to overexpress alpha globin in FL5.12 cells instead of a construct expressing alpha globin with an N-terminal FLAG-tag and an internal ribosomal entry site for GFP. The fusion construct ensured concomitant sorting of GFP and alpha globin. Ectopic expression of GFP-alpha globin was not accompanied by apoptosis in the presence of IL-3. Also the potent cell death inducer Bax was well tolerated in FL5.12 cells in the presence of IL-3. However, in contrast to GFP-Bax, GFP-alpha globin was difficult to enrich in FL5.12 cells, consistent with the pro-apoptotic role of alpha globin. Excessive and non-stabilized alpha globin is known to be harmful for erythrocytes and to induce apoptosis in erythroid precursors of patients with betathalassemia. Precipitation of alpha globin is assumed to be triggered by oxidation of heme-bound iron initiating structural perturbations that culminate in protein denaturation.
12,45 However, we did not find that cells overexpressing GFP-alpha globin were associated with increased heme levels. Therefore, toxicity due to oxidation of alpha globin cannot explain the difficulty to reach high expression levels of our construct in the presence of IL-3.
Raf/MEK/ERK and PI3K/Akt kinase cascades are the central survival signaling pathways in cytokinedependent FL5.12 cells triggered by IL-3. Both pathways are interwoven and together they control cell death by phosphorylating several apoptotic and cell cycle regulatory proteins like caspase-9, BAD, or FKHRL1. 8, 46, 47 The survival signaling cascade is immediately interrupted when IL-3 is missing, leading to subsequent dephosphorylation, activation of pro-apoptotic factors, and release of cytochrome c from mitochondria.
Upon IL-3 withdrawal, FL5.12 cells expressing GFPalpha globin displayed increased internucleosomal DNA fragmentation as assessed by TUNEL staining. The more alpha globin was enriched in the cells by sorting, the faster apoptosis was executed indicating that there was a dosedependent effect of alpha globin on apoptosis. GFP-alpha globin had a comparable effect on viability as GFP-Bax.
It has been reported earlier that cell death in FL5.12 cells induced by IL-3 deprivation was independent of caspases. 48 In contrast, we demonstrated that pan caspase inhibitor, zVAD-fmk, moderately but significantly delayed apoptosis triggered by the absence of cytokine. However, we could not prevent cell death completely even in the presence of high doses of zVAD-fmk. Inhibition of apoptosis by zVAD-fmk was less efficient in cells expressing GFP-alpha globin or GFP-Bax as in GFP expressing cells. This led to the conclusion that either caspaseindependent processes were involved or levels of active caspases were too high to be efficiently neutralized by the caspase inhibitor in FL5.12 transduced with GFP-alpha globin or GFP-Bax.
A parallel approach, in which we transduced FL5.12 cells with an antisense alpha globin construct, showed reduction of DEVDase activity by a factor of 2 as compared to GFP control cells in the absence of IL-3. In contrast, DNA fragmentation was prevented only marginally. Silencing of endogenous alpha globin was incomplete which may explain the partial reduction of DEVDase activity and cleavage of DNA.
Executioner caspases such as caspase-3, -6, and -7 are activated by proteolytic cleavage. Initiator caspases, however, do not necessarily require cleavage to become activated nor does cleavage of an initiator necessarily indicate activation. 4 We demonstrated that cell death induced by cytokine deprivation in FL5.12 cells was accompanied by significant cleavage of caspase-3 and -9 and moderate cleavage of caspase-2 and -8 as assessed by immunoblotting. We confirmed active caspase-8 and -9 using AMClabeled IETD and LEHD substrates by showing that both peptides were cleaved in FL5.12 cells growing without IL-3. To further assess the activity of caspase-2 and -3 we used a commercial assay detecting the cleavage of VD-VAD and DEVD, respectively. We found both substrates to be cleaved, however, due to very similar substrate requirements of caspases it cannot be fully excluded that also other caspases cleave the same substrates. For all caspase substrates tested we found that cells transduced with Bax or alpha globin exhibited stronger enzymatic activity than GFP control cells.
Abrogated phosphorylation of caspase-9 by Akt as well as increased activity of the mitochondrial apoptosis pathway can explain caspase-9 activation. 7 In the apoptosome, pro-caspase-9 becomes activated upon assembly with cytochrome c, Apaf-1, and ATP or ADP. 49 Caspase-8 is primarily involved in death receptor signaling. Depending on the intensity of the stimulus, caspase-8 triggers apoptosis via the mitochondrial pathway and/or through downstream caspase cascades. 5 Recently, however, the PI3-kinase/Akt survival signaling pathway was shown to regulate the expression of FLIP, a natural inhibitor of caspase-8 in endothelial cells. 50 This points at a potential connection between caspase-8 and Akt signaling and hence activation of caspase-8 upon growth factor deprivation in FL5.12 cells. Caspase-2 is widespread and highly expressed in hematopoietic cells 51 and it can trigger apoptosis via the non-mitochondrial and the mitochondrial apoptotic pathway with cytochrome c release. There is growing evidence that caspase-2 plays a central role in IL-3 dependent signaling; e.g. antisense caspase-2 has been reported to prevent apoptosis induced by cytokine removal in IL-3 dependent FDC-P1 cells, suggesting an essential role of caspase-2 in cell death induced by cytokine deprivation. 52 So far it has not been fully elucidated which mechanisms lead to caspase-2 activation. 53, 54 In cell-free systems, however, caspase-9 has been shown to be required for the activation of caspase-2 and other downstream caspases. 55 Besides processing of at least 42 of 58 known caspase substrates, caspase-3 can cleave caspase-2, -6, -7, and -9 and autoactivate itself. 56 In FL5.12 cells transduced with GFP-alpha globin three essential steps in the mitochondrial pathway were promoted compared to control cells: translocation of Bax from the cytosol to the membrane fraction, release of cytochrome c from mitochondria, and disappearance of fulllength Bid from cytosolic fraction, which suggests that it is cleaved and translocated to mitochondria. To date, two caspases are known to cleave Bid, caspase-2 and -8. Both caspases were found to be involved in IL-3 deprivation induced apoptosis in FL5.12 cells. tBid translocates to mitochondria and promotes conformational change, oligomerization and recruitment of Bax to the mitochondria. Subsequently cytochrome c is released. 38, 57 We have shown that Bcl-x L efficiently inhibited apoptosis accelerated by alpha globin. Both caspase activation and DNA fragmentation were found to be blocked in FL5.12 cells coexpressing alpha globin and Bcl-x L . Bclx L is known to counteract the pro-apoptotic effects of Bax and to prevent cytochrome c release induced by ectopically expressed Bax 58, 59 . We have shown earlier that Bcl-2 is a potent inhibitor of alpha globin-promoted apoptosis in FL5.12 cells. 17 Anti-apoptotic Bcl-2 resides in membranes of mitochondria, endoplasmatic reticulum and the nuclear envelope, and prevents Bax translocation to the mitochondria and cytochrome c release. 60 In addition, it has been shown that Bcl-2 has a direct function on caspase activation. Thus Bcl-x L is now the second member of the Bcl-2 family that counteracts the pro-apoptotic effect of alpha globin.
In summary, there is growing evidence that the function of alpha globin is not restricted to oxygen transport. Our data suggest that alpha globin is involved in pro-apoptotic processes in a wide range of cells. Whether the pro-apoptotic function is unique to alpha globin or a rather globin-specific phenomenon needs to be investigated in future experiments. These findings are reminiscent of observations made for cytochrome c by Liu et al. nine years ago when cytochrome c, which was exclusively believed to function as an electron carrier in the respiratory chain of mitochondria, was also found to be an essential component of the apoptosome. 61 It remains to be further elucidated how alpha globin promotes its "Bax-like" cell death.
Conclusions
We have shown that several specific apoptotic stimuli induce upregulation of alpha globin in the hematopoietic pro-B cell line, FL5.12, as well as in other cell lines studied. Alpha globin was not associated with heme. Also no formation of hemoglobin was observed. Upregulation of alpha globin was not associated with differentiation down the erythroid lineage. All this suggests that alpha globin possesses functions other than oxygen transport in erythrocytes. We observed that overexpression of GFPalpha globin accelerated the progression of apoptosis to a similar extent as overexpression of GFP-Bax while downregulation of endogenous alpha globin with antisense alpha globin diminished DEVDase activity. Bax and cytochrome c were activated, indicating that alpha globin accelerates the mitochondrial apoptotic pathway, where it plays a presently unknown function.
